A BREAKTHROUGH HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...

Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...

For more than two decades, the global community has united to fight the HIV pandemic, achieving remarkable progress. New HIV transmissions and AIDS-related deaths have dropped significantly, and ...

A dults with HIV and obesity who switched from an antiretroviral therapy (ART) regimen with an integrase strand transfer ...

Long-acting injectable PrEP may improve access, protection and adherence, especially for young people and pregnant women, according to Hasina Subedar, a senior technical advisor at South Africa’s ...

Let us refresh the old gold Buddhist tale of The Quail and the Net: ldquo;Long ago a flock of quails lived in a forest .

The U.S. Senate has opened debate on a $9 billion rescission bill to claw back foreign aid and other funding not aligned with ...

A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...

The temporary suspension of PEPFAR has disrupted preventive treatments, infant testing, and the work of community health ...

New World Health Organisation (WHO) recommendations for the use of long-acting HIV prevention and treatment are a welcome boost in the global efforts to end ...